Key Highlights
- Salesforce delivered adjusted earnings per share of $5.90, significantly exceeding the $3.27 Wall Street consensus, while revenue climbed 10.8% to $11.35 billion
- The cloud software giant deepened its Anthropic collaboration, embedding Claude AI into Agentforce and unveiling “Claudeforce”
- Combined annual recurring revenue for Agentforce and Data Cloud neared $3.9 billion, with Agentforce individually contributing approximately $1.5 billion
- Executive leadership elevated fiscal 2027 revenue projections to a range of $46.1 billion to $46.4 billion
- Wolfe Research issued a “strong buy” upgrade on CRM shares while Truist Securities established a $300 price objective
Salesforce (CRM) began Monday’s trading session at $256.60, hovering close to its 12-month peak of $269.11. The stock’s momentum stems from impressive quarterly results and an expanded strategic alliance with Anthropic that has captured investor enthusiasm.
For the quarter concluding on August 26th, the enterprise software leader posted adjusted earnings per share of $5.90, substantially surpassing the Street’s $3.27 expectation. Total revenue reached $11.35 billion, representing a 10.8% year-over-year increase and marginally exceeding the $11.33 billion forecast.
However, there’s an important nuance to consider. Approximately $2.53 of that $5.90 earnings figure originated from strategic investment gains, with an estimated $2.7 billion unrealized gain attributed to Salesforce’s equity position in Anthropic. While legitimate value, this differs fundamentally from operational earnings.
The expanded Anthropic collaboration represents another pivotal development. Salesforce strengthened its relationship with the artificial intelligence firm, directly incorporating Claude into Agentforce while introducing “Claudeforce,” which seamlessly integrates Salesforce CRM capabilities within Claude’s environment. Market participants responded favorably.
The combined annual recurring revenue for Agentforce and Data Cloud is nearing $3.9 billion, with Agentforce independently generating approximately $1.5 billion. These AI-driven revenue figures are precisely what captures Wall Street’s imagination.
Wall Street’s Response
Analyst sentiment trends largely positive. Wolfe Research elevated CRM to “strong buy” status. Truist Securities established a $300 price objective, JPMorgan adjusted to $265, and Mizuho similarly positioned at $265. BMO Capital Markets increased its target from $230 to $260 while maintaining an “outperform” designation. Both Evercore and Citizens JMP Securities reaffirmed their outperform recommendations.
Skepticism persists in certain quarters. UBS, Citi, Morgan Stanley, and Wells Fargo maintained neutral-equivalent ratings. Wells Fargo elevated its target from $205 to $230 but retained its “equal weight” stance. HC Wainwright issued a downgrade to “negative” during June. Bank of America continues with an “underperform” rating and $160 target. The aggregate consensus establishes a “Moderate Buy” with a median price target of $261.15.
Certain cautious analysts have highlighted that Anthropic might ultimately dominate the AI orchestration infrastructure, potentially constraining Salesforce’s strategic flexibility over the long term, despite near-term advantages.
Institutional Investment Trends
Substantial institutional capital has flowed into CRM. BlackRock established a fresh position valued at approximately $11.4 billion. J. Stern and Co. dramatically expanded its holdings by over 24,000%, now controlling more than 47 million shares worth roughly $12.6 billion. Bank of America Corp DE and Norges Bank similarly initiated new positions. Institutional ownership currently represents 80.43% of outstanding shares.
Company leadership raised fiscal 2027 revenue guidance to $46.1 billion to $46.4 billion and established Q3 2027 earnings per share guidance at $3.42 to $3.44. The stock’s 50-day moving average stands at $181.24 and its 200-day at $182.47, both considerably below current trading levels.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
